New phase of EU Central Asian Drug Action Programme (CADAP) celebrated today

The latest phase of the EU-funded Central Asian Drug Action Programme (CADAP 7), is celebrated today in Bishkek (Kyrgyzstan). The EMCDDA is participating in the official launch ceremony as one of the EU agencies providing ad hoc support to the programme until 2024 (1). CADAP is a drug demand reduction initiative designed to promote the development of effective, comprehensive drug policies, based on scientific evidence and best practice. 29.03.2022